Skip to main navigation
Skip to search
Skip to main content
University of Johannesburg Home
Home
Scholars
Research entities
Research output
Press/Media
Equipment & facilities
Prestigious awards
Search by expertise, name or affiliation
Photodynamic therapy for metastatic melanoma treatment: A review
Channay Naidoo Honors
,
Cherie Ann Kruger
,
Heidi Abrahamse
Complementary Medicine
Laser Research Centre
University of Johannesburg
Research output
:
Contribution to journal
›
Review article
›
peer-review
89
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Photodynamic therapy for metastatic melanoma treatment: A review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Photodynamic Therapy
100%
Metastatic Melanoma
100%
Melanoma Treatment
100%
Photosensitizer
60%
Nanoparticles
40%
Melanoma
40%
Conventional Treatment
40%
Chemotherapy
20%
Biocompatibility
20%
Targeted Photodynamic Therapy
20%
Drug Delivery
20%
Cell Death
20%
Reactive Oxygen Species
20%
Therapy Treatment
20%
Cell Surface Receptor
20%
Drug Carrier System
20%
Therapeutic Agents
20%
Nano-drug Delivery System
20%
Specific Wavelength
20%
Targeted Nanoparticles
20%
Alternative Therapy
20%
Combinative
20%
Skin Cancer
20%
High Loading Capacity
20%
Monoclonal Antibody
20%
Smart Drugs
20%
Recombinant Interferon
20%
Nanophotosensitizer
20%
High-dose interleukin-2
20%
Cellular Uptake Mechanism
20%
Invasive Melanoma
20%
Nonmalignant
20%
Dacarbazine
20%
Will of the People
20%
Medicine and Dentistry
Photodynamic Therapy
100%
Metastatic Melanoma
100%
Nanoparticle
80%
Photosensitizer
80%
Nodular Melanoma
80%
Drug Delivery System
20%
Side Effect
20%
Drug Carrier
20%
Therapeutic Agent
20%
Drug Megadose
20%
Reactive Oxygen Species
20%
Cell Death
20%
Cell Surface Receptor
20%
Monoclonal Antibody
20%
Skin Cancer
20%
Recombinant Interferon
20%
Interleukin 2
20%
Dacarbazine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Photodynamic Therapy
100%
Metastatic Melanoma
100%
Nanoparticle
80%
Photosensitizer
80%
Melanoma
80%
Chemotherapy
20%
Drug Delivery System
20%
Skin Cancer
20%
Reactive Oxygen Metabolite
20%
Side Effect
20%
Cell Surface Receptor
20%
Monoclonal Antibody
20%
Drug Carrier
20%
Interleukin 2
20%
Dacarbazine
20%
Recombinant Interferon
20%